Our Grants

CIRM provides funding across five key areas: Infrastructure, Education, Discovery Research, Translational Research, and Clinical Research. By supporting projects at every stage of development, from initial discovery to clinical trials, CIRM drives progress in regenerative medicine and accelerates innovative therapies to patients.

Check out our portfolio of awards below. Click here to see a list of People We’ve Funded. Click here to see a list of our Funded Institutions.

All CIRM Grants

Search Filters »

Institution Researcher name Grant Type Grant Title Award Value
Scripps Research Institute Stuart A Lipton Discovery Research Projects Repurposing Aminoadamantane Nitrate Compounds to Inhibit SARS-CoV-2 Viral Activity and to Protect the Brain from Viral-Related Damage $150,000
University of California, Los Angeles Dr. Brigitte N Gomperts Discovery Research Projects Identifying a lead compound for COVID19 using high throughput screening with lung stem cell organoids $149,998
University of California, Irvine Daniela A. Bota Conference – The 2020 Grantee Meeting 2020 CIRM Grantee Meeting $176,762
University of California, Irvine Daniela A. Bota Conference – The Alpha Stem Cell Clinic Annual Symposium 2023 Alpha Stem Cell Clinic Annual Symposium $49,512
University of California, Davis Dr Mehrdad Abedi Conference – The Alpha Stem Cell Clinic Annual Symposium CIRM – Leading the New Era of Living Medicines $6,738
Boston Children’s Hospital David Williams Cure Sickle Cell Initiative Clinical Trial Stage Projects Phase 2 Study of Hematopoietic Stem Cell Gene Transfer Inducing Fetal Hemoglobin in Sickle Cell Disease $8,333,581
University of California, San Francisco Mark C. Walters M.D. Cure Sickle Cell Initiative Clinical Trial Stage Projects Transplantation of CRISPR-CAS9 Corrected Hematopoietic Stem Cells (CRISPR_SCD001) in Patients with Severe Sickle Cell Disease $8,389,407
ExCellThera Inc. Dr Pierre Caudrelier Cure Sickle Cell Initiative Clinical Trial Stage Projects A Phase 1 Study of ECT-001 Expanded Cord Blood and Myeloablative Regimen with Reduced Toxicity in Patients with Severe Sickle Cell Disease. $600,000
University of California, San Diego Armin Blesch Progression Award – Discovery Stage Research Projects Simplification of Excipient Solution for Implanting Candidate Human H9-scNSC Cell Line for Spinal Cord Injury $180,000
Stanford University Dr. Helen M Blau Progression Award – Discovery Stage Research Projects Stimulating endogenous muscle stem cells to counter muscle wasting $237,060
University of California, Irvine Dr. Brian J. Cummings Progression Award – Discovery Stage Research Projects Human neural stem cell (hNSC) derived exosomes vs CSC14 hNSCs for the treatment of traumatic brain injury (TBI) $202,667
University of California, Berkeley Kevin E. Healy Progression Award – Discovery Stage Research Projects Safety “Clinical Trial” of the Cardiac Liability of COVID19 Polytherapy $224,500
University of California, Los Angeles Dr. Caroline Y. Kuo Progression Award – Discovery Stage Research Projects Evaluation of Gene Therapy Approaches for Autosomal Recessive Hyper IgE Syndrome Due to Mutations in DOCK8 $234,000
Neurona Therapeutics Dr. Cory R Nicholas Progression Award – Discovery Stage Research Projects Global gene expression profiling of single inhibitory neurons derived from human stem cells $202,500
Stanford University Professor Hiromitsu Nakauchi Progression Award – Discovery Stage Research Projects Using metabolic pausing for maintaining stable and high-quality pluripotent stem cells $208,422
Aspen Neuroscience Dr. Andres Bratt-Leal Progression Award – Discovery Stage Research Projects Autologous therapy for Parkinson’s disease: single cell RNAseq for in depth characterization of transplanted cells $177,579
1 … 21 22 23 24 25 26 27 28 29 30 31

How to Apply

Learn More

Explore CIRM-Funded Clinical Trials

Learn More

Managing Your Grant

Learn More

See our Active Awards Portfolio

Learn More